Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer

Response to neoadjuvant chemotherapy (NAC) in triple negative breast cancer (TNBC) is highly prognostic and determines whether adjuvant chemotherapy is needed if residual tumor is found at surgery. To evaluate the predictive and prognostic values of circulating tumor DNA (ctDNA) in this setting, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavallone, Luca, Aguilar-Mahecha, Adriana, Lafleur, Josiane, Brousse, Susie, Aldamry, Mohammed, Roseshter, Talia, Lan, Cathy, Alirezaie, Najmeh, Bareke, Eric, Majewski, Jacek, Ferrario, Cristiano, Hassan, Saima, Discepola, Federico, Seguin, Carole, Mihalcioiu, Catalin, Marcus, Elizabeth A., Robidoux, André, Roy, Josée-Anne, Pelmus, Manuela, Basik, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477566/
https://www.ncbi.nlm.nih.gov/pubmed/32895401
http://dx.doi.org/10.1038/s41598-020-71236-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477566/
https://www.ncbi.nlm.nih.gov/pubmed/32895401
http://dx.doi.org/10.1038/s41598-020-71236-y

Ejemplares similares